Skip to main content
logo
Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
5.50
+0.21 (3.97%)
At close: Apr 1, 2026, 4:00 PM EDT
5.49
-0.01 (-0.18%)
After-hours: Apr 1, 2026, 4:00 PM EDT

Verrica Pharmaceuticals Revenue

In the year 2025, Verrica Pharmaceuticals had annual revenue of $35.58M with 370.22% growth. Verrica Pharmaceuticals had revenue of $5.09M in the quarter ending December 31, 2025, with 1,380.23% growth.

Revenue (ttm)
$35.58M
Revenue Growth
+370.22%
P/S Ratio
2.65
Revenue / Employee
$468,118
Employees
76
Market Cap
94.48M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202535.58M28.01M370.22%
Dec 31, 20247.57M2.44M47.66%
Dec 31, 20235.12M-3.91M-43.27%
Dec 31, 20229.03M-2.97M-24.73%
Dec 31, 202112.00M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Q32 Bio53.74M
Sangamo Therapeutics39.55M
Seer, Inc.16.58M
Pyxis Oncology13.86M
Coya Therapeutics7.95M
Spruce Biosciences697.00K
Revenue Rankings

VRCA News

More News